Financhill
Back

Keros Therapeutics 10K Form

Buy
56

KROS
Keros Therapeutics

Last Price:
50.89
Seasonality Move:
16.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KROS News And Ratings

See the #1 stock for the next 7 days that we like better than KROS

KROS Financial Statistics

Sales & Book Value

Annual Sales: $151K
Cash Flow: $-45.51M
Price / Cash Flow: 0
Annual Sales: $12.59
Price / Book: 3.86

Profitability

EPS (TTM): -5.15000
Net Income (TTM): $-160.3M
Gross Margin: --
Return on Equity: -45.46%
Return on Assets: -41.68%

Keros Therapeutics Earnings Forecast

Key Keros Therapeutics Financial Ratios

  • The Research & Development expenses have been 89,574.83% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of KROS is -101,319.21% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Keros Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KROS
CUSIP: 492327
Website: kerostx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 24.74
Quick Ratio: 23.73

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KROS Technical Analysis vs Fundamental Analysis

Buy
56
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics a Buy or a Sell?